Amalgamation of Sresta Natural Bioproducts Private Limited and Wimco Limited with the Company

Nclt Scheme FiledStrategic Transactions View source PDF

ITC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.1%1-day move

₹310.75

prior close

₹309.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.1+0.1-0.0-1.1-1.6-3.2-1.9-1.1+0.1-7.4-9.9-7.3—

Up moveDown movePending

AI summary

ITC Limited's Scheme of Amalgamation involving two subsidiaries—Sresta Natural Bioproducts Private Limited and Wimco Limited—has been sanctioned by the NCLT Kolkata and Hyderabad Benches. The Appointed Dates were 13th June 2025 for Sresta and 1st April 2025 for Wimco, with the Effective Date set as 1st June 2026. From this date, both subsidiaries will be dissolved without winding up and cease to be ITC's subsidiaries. Sresta's two foreign subsidiaries—Sresta Global FZE (UAE) and Fyve Elements LLC (USA)—will become direct wholly owned subsidiaries of ITC.

Likely market impact

This consolidation simplifies ITC's corporate structure by merging these subsidiaries directly into the parent company, strengthening its organic portfolio without external acquisition costs. The stock remains unaffected as this is an internal restructuring already anticipated by the market.